Cellectis SA (CLLS)
1.43
+0.03
(+2.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.41
-0.02
(-1.40%)
After-Hours: 20:00
Cellectis Gross Profit Margin (Quarterly) : 15.62% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.62% |
| March 31, 2026 | 21.50% |
| December 31, 2025 | 50.92% |
| September 30, 2025 | 85.76% |
| June 30, 2025 | 70.00% |
| March 31, 2025 | 53.77% |
| December 31, 2024 | 54.16% |
| September 30, 2024 | 70.86% |
| June 30, 2024 | 41.35% |
| March 31, 2024 | -0.91% |
| December 31, 2023 | -1.79K% |
| September 30, 2023 | -2.89K% |
| June 30, 2023 | -2.38K% |
| March 31, 2023 | -3.35K% |
| December 31, 2022 | 95.69% |
| September 30, 2022 | -2.57K% |
| June 30, 2022 | -269.5% |
| March 31, 2022 | -217.5% |
| December 31, 2021 | 54.10% |
| September 30, 2021 | -10.84% |
| June 30, 2021 | -5.17% |
| March 31, 2021 | 68.18% |
| December 31, 2020 | -30.22% |
| Date | Value |
|---|---|
| September 30, 2020 | -26.56% |
| June 30, 2020 | -100.9% |
| March 31, 2020 | 90.82% |
| December 31, 2019 | -27.79% |
| September 30, 2019 | 49.85% |
| June 30, 2019 | -112.2% |
| March 31, 2019 | -54.83% |
| December 31, 2018 | 25.62% |
| September 30, 2018 | 4.19% |
| June 30, 2018 | 82.66% |
| March 31, 2018 | 85.21% |
| December 31, 2017 | 72.37% |
| September 30, 2017 | 84.32% |
| June 30, 2017 | 86.28% |
| March 31, 2017 | 86.23% |
| December 31, 2016 | 88.93% |
| September 30, 2016 | 93.83% |
| June 30, 2016 | 96.73% |
| March 31, 2016 | 90.37% |
| December 31, 2015 | 95.10% |
| September 30, 2015 | 95.61% |
| June 30, 2015 | 94.65% |
| March 31, 2015 | 94.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Akari Therapeutics Plc | -- |
| Autolus Therapeutics Plc | 55.20% |
| Evaxion AS | -- |
| Bicycle Therapeutics Plc | -69.64% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -87.23% |
| Return on Assets | -20.61% |
| Return on Invested Capital | -34.74% |
| Profit Margin (Quarterly) | -417.3% |
| Operating Margin (Quarterly) | -487.4% |
| Return on Net Operating Assets | -88.13% |